Oncology Company Hercules Pharmaceuticals to Present AhR Inhibitor Efficacy Results at Upcoming AACR Meeting on Monday April 16
The Aryl Hydrocarbon Receptor (AHR) as a Driver of Cancer Immunosuppression Leiden, The Netherlands, April 13, 2018 / B3C newswire / -- Hercules Pharmaceuticals, a Dutch biopharmaceutical company developing innovative anti-cancer drugs will present a …